cbdMD, Inc. (YCBD)
0.8523
-0.07
(-7.65%)
USD |
NYAM |
Feb 09, 16:00
0.861
+0.01
(+1.02%)
After-Hours: 20:00
cbdMD EPS Diluted (Quarterly) : -0.0762 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cassava Sciences, Inc. | -0.2237 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.68M |
| Revenue (Quarterly) | 4.721M |
| Total Expenses (Quarterly) | 5.401M |
| Enterprise Value | 6.111M |
| Gross Profit Margin (Quarterly) | 53.28% |
| Profit Margin (Quarterly) | -14.40% |
| Earnings Yield | -460.3% |
| Normalized Earnings Yield | -473.06 |